Please check your internet connection and try again.
# Intravenous Dexamethasone
## Overview
Dexamethasone is a potent synthetic corticosteroid with strong anti-inflammatory and immunosuppressive effects.
## Primary Indications
* Allergic states
* Dermatologic conditions
* Endocrine disorders
* Gastrointestinal diseases
* Hematologic disorders
* Neoplastic diseases (adjunct therapy)
* Nervous system conditions
* Ophthalmic diseases
* Respiratory diseases
* Rheumatic disorders
* Certain infections (e.g., tuberculous meningitis, visceral larva migrans)
* Cerebral edema associated with brain tumors or surgery
* Diagnostic testing of adrenal gland function
## Adult Dosing
Dosing is highly variable and depends on the specific indication.
* **Allergic states, dermatologic, ophthalmic, respiratory diseases:** Typically 0.5 mg to 9 mg daily in divided doses or once daily.
* **Cerebral edema:** 10 mg initially, followed by 4 mg every 6 hours as needed. May be tapered.
* **Adrenal insufficiency:** 1 mg to 2 mg daily.
* **Neoplastic diseases:** Doses range from 4 mg to 10 mg daily, or higher, based on protocol.
* **Diagnostic testing:** Specific regimens apply (e.g., dexamethasone suppression test).
## Pediatric Dosing
Dosing is weight-based and depends on the indication.
* **General anti-inflammatory/immunosuppressive:** 0.02-0.3 mg/kg/day divided every 6-12 hours. Maximum dose not established, often guided by adult protocols.
* **Cerebral edema:** Similar to adults, but pediatric dosing protocols should be consulted.
## Dose Adjustments
* **Renal impairment:** No specific dose adjustment is routinely recommended, but monitor for increased adverse effects.
* **Hepatic impairment:** May require dose adjustments; monitor closely.
## Contraindications
* Systemic fungal infections
* Known hypersensitivity to the drug or its components
## Adverse Effects
Common adverse effects include hyperglycemia, insomnia, mood changes, increased appetite, fluid retention, hypertension, impaired wound healing, osteoporosis (long-term use), adrenal suppression, increased susceptibility to infection, Cushingoid features, and gastrointestinal irritation.
## Key Drug Interactions
* **CYP3A4 inducers (e.g., rifampin, phenytoin, carbamazepine, phenobarbital):** May decrease dexamethasone levels and efficacy.
* **CYP3A4 inhibitors (e.g., ketoconazole, itraconazole, macrolides):** May increase dexamethasone levels.
* **Diuretics (non-potassium sparing):** Increased risk of hypokalemia.
* **Antidiabetic agents:** May decrease efficacy.
* **Live vaccines:** Increased risk of infection; avoid concurrent use.
## Monitoring
* Blood glucose levels
* Electrolytes (potassium, sodium)
* Blood pressure
* Signs of infection
* Signs of adrenal suppression (especially with prolonged use or abrupt discontinuation)
* Bone density (long-term therapy)
* Growth and development (pediatric patients)
## Clinical Pearls
* Administer IV dexamethasone undiluted or diluted in a compatible IV fluid if needed.
* Administer intramuscularly if IV access is not feasible.
* Taper dose gradually when discontinuing or reducing dose after prolonged therapy to prevent adrenal insufficiency.
* Consider prophylactic measures for *Pneumocystis jirovecii* pneumonia and gastric protection (e.g., PPI) in certain patient populations.
* Dexamethasone is often used as a placebo in clinical trials due to its potent effects.
***
**Disclaimer:** This information is intended for clinical pharmacists and prescribers. It is essential to consult the most current official prescribing information and relevant institutional protocols for definitive guidance, as recommendations and indications can change.
